News & Updates
Filter by Specialty:
Show Multimedia Only

Datopotamab deruxtecan improves survival in breast cancer patients not eligible for immunotherapy
06 Nov 2025
byStephen Padilla
First-line treatment with datopotamab deruxtecan (Dato-DXd) results in statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS) compared with chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), as shown by the results of the phase III TROPION-Breast02 trial.
Datopotamab deruxtecan improves survival in breast cancer patients not eligible for immunotherapy
06 Nov 2025
High BMI tied to ulnar nerve entrapment development in nondiabetic individuals
06 Nov 2025
byAudrey Abella
A longitudinal study from Sweden shows an association between high BMI and the development of ulnar nerve entrapment (UNE) in a middle-aged cohort of individuals without diabetes from northern Europe, with over 25 years of follow-up.







